Live Breaking News & Updates on Artax Science

Stay updated with breaking news from Artax science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company's Board of Directors

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today. ....

United Kingdom , Andre Hoekema , Artax Biopharma , Joseph Lobacki , Company Board Of Directors , Genentech Inc , Leiden University , Prnewswire Artax Biopharma Inc , Invitrogen Corporation , Life Sciences , Corporate Development Europe , Company Welcomes Dr , Company Mergers Acquisitions , Business Development , Biotech Veteran , Track Record , Successful Industry Collaborations , Artax Biopharma Board , Chief Executive , Chief Business Officer , Pharma Partnering , Intellectual Property , Managing Director , Molecular Probes Europe , Fibrocor Therapeutics , Artax Science ,

Artax Biopharma Expands Company's Scientific Advisory Board

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today. ....

Stanford University , United States , San Diego , United Kingdom , Noord Holland , Lawrence Steinman , Batty Jr , Artax Biopharma , Balbino Alarc , Eli Lilly , Jamesg Krueger , D Martin Carter , Raif Geha , Ajay Nirula , D Scott Batty Jr , Cox Terhorst , School Of Medicine , National Research Council Of Spain , Beth Israel Deaconess Medical Center , Dermatology Division At Children Hospital , Genetics At Stanford University , Lilly Biotechnology Center , University Of Texas Southwestern Medical School , Head Of The Laboratory For Investigative Dermatology , Cornell University Medical College , Rockefeller University ,

Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer

/PRNewswire/ Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today. ....

United Kingdom , Georgetown University , District Of Columbia , United States , Walter Reed Army Medical Center , Artax Biopharma , D Scott Batty Jr , Bristol Myers Squibb , Joseph Lobacki , National Institute Of Diabetes , Artax Biopharma Inc , National Institutes Of Health , Oncology Group , Tissue Transplant Research Center , Liver Transplantation At Georgetown University Hospital , Immunarray Ltd , Us Army Medical Corps , University Of Pittsburgh , Scientific Affairs , Tufts University School Of Medicine , Global Medical Affairs For Genzyme , Clinical Development , Fcti Inc , Batty Brings Significant Leadership Experience , Global Immunology , Successful Financing ,

Artax Biopharma Announces First-in-Human Dosing in Phase 1 Clinical Trial for AX-158, Company's First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today. ....

Artax Biopharma , Joseph Lobacki , Artax Biopharma Chief Executive Officer Joseph , Artax Science ,

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Lawrence Steinman , Artax Biopharma , Joseph Lobacki , Stanford University Zimmerman Professor Of Neurology , Stanford University Zimmerman Professor , Artax Scientific Advisory Board , Biopharma Chief Executive Officer Joseph Lobacki , Artax Science , லாரன்ஸ் ஸ்டெய்ன்மேன் , ஸ்டான்போர்ட் பல்கலைக்கழகம் ஸிம்மர்மந் ப்ரொஃபெஸர் ஆஃப் நரம்பியல் , ஸ்டான்போர்ட் பல்கலைக்கழகம் ஸிம்மர்மந் ப்ரொஃபெஸர் ,